Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B1BQ
|
|||
| Former ID |
DNC004652
|
|||
| Drug Name |
1,1,1-Trifluoro-nonadecan-2-one
|
|||
| Synonyms |
2-Nonadecanone, 1,1,1-trifluoro-; CHEMBL89946; 1,1,1-trifluorononadecan-2-one; 81124-01-8; 1,1,1-Trifluoro-nonadecan-2-one; AC1L4IKT; CTK5E8478; DTXSID90230910; 1,1,1-Trifluoro-2-nonadecanone; 2-Nonadecanone,1,1,1-trifluoro-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H35F3O
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCCCCCC(=O)C(F)(F)F
|
|||
| InChI |
1S/C19H35F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(23)19(20,21)22/h2-17H2,1H3
|
|||
| InChIKey |
SYQIFPOSGNRRCM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 81124-01-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.